For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) was $16.51 for the day, down -4.01% from the previous closing price of $17.20. In other words, the price has decreased by -$4.01 from its previous closing price. On the day, 0.88 million shares were traded. CNTA stock price reached its highest trading level at $17.355 during the session, while it also had its lowest trading level at $16.1701.
Ratios:
Our analysis of CNTA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.52 and its Current Ratio is at 21.52. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
On September 20, 2024, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $11 to $26.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.B. Riley Securities initiated its Buy rating on September 19, 2024, with a $33 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 17 ’25 when HUSSAIN IQBAL J bought 6,000 shares for $17.07 per share.
CHAO DAVID M bought 7,000 shares of CNTA for $119,490 on Mar 17 ’25. On Feb 25 ’25, another insider, Weinhoff Gregory M, who serves as the Chief Business Officer of the company, sold 11,494 shares for $15.25 each. As a result, the insider received 175,270 and left with 134,021 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2176761088 and an Enterprise Value of 1743039872. For the stock, the TTM Price-to-Sale (P/S) ratio is 314.57 while its Price-to-Book (P/B) ratio in mrq is 4.35. Its current Enterprise Value per Revenue stands at 254.347 whereas that against EBITDA is -10.806.
Stock Price History:
The Beta on a monthly basis for CNTA is 1.45, which has changed by 0.39442563 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, CNTA has reached a high of $19.09, while it has fallen to a 52-week low of $7.75. The 50-Day Moving Average of the stock is 0.06%, while the 200-Day Moving Average is calculated to be 14.82%.
Shares Statistics:
CNTA traded an average of 806.67K shares per day over the past three months and 1085860 shares per day over the past ten days. A total of 131.66M shares are outstanding, with a floating share count of 79.75M. Insiders hold about 39.43% of the company’s shares, while institutions hold 55.19% stake in the company. Shares short for CNTA as of 1740700800 were 5458260 with a Short Ratio of 6.77, compared to 1738281600 on 3050896. Therefore, it implies a Short% of Shares Outstanding of 5458260 and a Short% of Float of 5.08.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
